Alpha Sense BI

MARCH 13, 2024

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. Hospital and health system deal activity increased 27% year over year in 2023 , and a flurry of deals has been announced since the beginning of the year.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

SEPTEMBER 15, 2023

M&A activity is declining across global markets. There is an increased focus on global healthcare access equity. M&A Activity is at a Decline Across Global Markets Though the medtech dealmaking space remained quiet in 2022 , analysts predicted a resurgence in 2023. There is an increased focus on sustainability and ESG.

Hospitals 105

Hospitals Due Diligence Innovation Globalization 105

Alpha Sense BI

OCTOBER 6, 2023

Though medical devices are not new to the medtech market, their most recent boom can be attributed to the 2020 global pandemic. Like most other industries, this space was initially adversely affected by COVID-19 due to supply chain issues and reduced budgets for product innovation that brought production to a halt. from 2022 to 2030.

Hospitals 59

Hospitals Startups Due Diligence Innovation 59

Alpha Sense BI

MAY 5, 2023

After three volatile years, rife with challenging macroeconomic conditions — from a global pandemic and wars to far-reaching supply chain issues — the M&A space has its fair share of ups and downs. ESG is also playing an important role for PE investors, who are increasingly relying on pre-deal ESG due diligence in M&A dealmaking.

Biotech 97

Biotech Capital Banking Startups 97